Malta - English - Medicines Authority

amomed pharma gmbh storchengasse 1, 1150 vienna, austria - landiolol - powder for solution for infusion - landiolol 600 mg - beta blocking agents

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - argipressin - concentrate for solution for infusion - argipressin 40 iu / 2 ml - argipressin - embesin is indicated for the treatment of catecholamine-refractory hypotension following septic shock in patients older than 18 years. a catecholamine-refractory hypotension is present if the mean arterial blood pressure cannot be stabilized to 65 – 75 mmhg despite adequate volume substitution and application of catecholamines.

European Union - English - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Malta - English - Medicines Authority

amomed pharma gmbh storchengasse 1, 1150 vienna, austria - landiolol - powder for solution for infusion - landiolol 300 mg - beta blocking agents

Malta - English - Medicines Authority

amomed pharma gmbh storchengasse 1, 1150 vienna, austria - landiolol - concentrate for solution for injection - landiolol 10 mg/ml - beta blocking agents

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - esmolol hydrochloride - solution for injection - esmolol hydrochloride 10 mg/ml - esmolol - esmolol amomed 100 mg/10 ml is indicated for supraventricular tachycardia (except for pre-excitation syndromes) and for the rapid control of the ventricular rate in adult patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.esmolol amomed 100 mg/10 ml is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia in adult patients where, in the physician’s judgement the rapid heart rate requires specific intervention.esmolol amomed 100 mg/10 ml is not intended for use in chronic settings.

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - esmolol hydrochloride - solution for injection - esmolol hydrochloride 100 mg / 10 ml - esmolol - esmolol amomed 100 mg/10 ml is indicated for supraventricular tachycardia (except for pre-excitation syndromes) and for the rapid control of the ventricular rate in adult patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.esmolol amomed 100 mg/10 ml is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia in adult patients where, in the physician’s judgement the rapid heart rate requires specific intervention.esmolol amomed 100 mg/10 ml is not intended for use in chronic settings.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - esmolol hydrochloride - powder for solution for infusion - 2.5gram